Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, is a gammaherpesvirus associated with Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma (10, 11, 17, 18) . KSHV infection is predominantly latent, and the virus persists in the nuclei of latently infected cells as a multiple-copy, covalently closed, extrachromosomal episome (16) .
The KSHV latency-associated nuclear antigen (LANA) mediates the replication and episome persistence of DNA containing the KSHV terminal repeat (TR) sequence (2, 13, 24, 27, 29, 39, 54) . LANA tethers episomes to mitotic chromosomes to efficiently segregate KSHV DNA to progeny nuclei. A similar tethering mechanism is used by the EBNA1 and E2 proteins to mediate the persistence of Epstein-Barr virus and papillomavirus episomes, respectively (6, 30, 31, 36, 44, 52, 53) .
C-terminal LANA specifically binds a 20-bp sequence within TR DNA with high affinity. C-terminal LANA oligomerizes to bind TR DNA, and the oligomerization is critical for DNA binding (3, 14, 24, 25, 33, 39, 43) . In the absence of TR DNA binding, LANA cannot mediate DNA replication or episome persistence.
LANA contains two independent chromosome association regions; one is in the N-terminal region (requiring amino acids 5 to 13) (4, 37, 40, 51) , and another is in the C-terminal domain (amino acids 996 to 1139) (32, 34) . N-terminal LANA is diffusely distributed across mitotic chromosomes by direct binding to core histones H2A and H2B (5) . This N-terminal chromosome binding is required for both replication and persistence of TR DNA (4, 37) . C-terminal LANA also binds chromatin (8, 34, 40, 43, 46, 48) and preferentially concentrates to paired dots at pericentromeric and peritelomeric regions of a subset of mitotic chromosomes (32) .
Scanning alanine mutagenesis of C-terminal LANA. We investigated LANA C-terminal TR DNA binding, oligomerization, and chromosome association by using alanine scanning substitutions. We previously localized LANA oligomerization, C-terminal chromosome attachment, and DNA binding to amino acids 996 to 1139; within this region, the function of amino acids 1007 to 1021 was determined to be unimportant for self-association and chromosome attachment but essential for DNA binding (32, 33) . Thus, amino acids 1023 to 1145 were targeted for alanine substitutions. Predominantly triple-alanine substitutions were used. Alanines were substituted for LANA residues in green fluorescent protein (GFP) fused with LANA 933-1162 (thirty-six mutants) or LANA 982-1162 (four mutants) (Fig. 1A) . GFP does not interfere with LANA chromosome association or its ability to mediate episome persistence (4, 5, 47) . Alanine substitution mutations in GFP LANA 933-1162 were generated by QuikChange PCR mutagenesis (Stratagene) with the oligonucleotides listed in Table 1 1061 were generated in GFP LANA 982-1162 by an alternate method of PCR mutagenesis; for each, the reverse primer (Table 1) was used with EF primer ATCTCGCGAATACCGCTATGTACTCAG and the forward primer (Table 1) was used with EE primer ACAGATATCTT ATGTCATTTCCTG to amplify initial PCR products from the full-length LANA sequence. These products were combined for a second round of PCR with the EE and EF oligonucleotides. The subsequent PCR product was cloned into GFP NLS, which contains the enhanced GFP fused to a nuclear localization signal (NLS) in EGFP-C1 (Clontech) (30) . All PCR-generated clones were confirmed by sequencing. In each mutant, the indicated residues are mutated to alanines (Table 2) . For instance, GFP LANA 933-1162 1023 QID 1025 has LANA residues 1023 QID 1025 replaced with alanines. Native alanine residues were left unchanged.
No specific residues are essential for LANA oligomerization. We assayed each mutant for the ability to oligomerize with wild-type LANA in coimmunoprecipitation experiments. Lipofectamine 2000 (Invitrogen) was used to cotransfect COS cells (ϳ4 ϫ 10 6 ) with 12 g of FLAG epitope-tagged LANA (F-LANA) (2) 4 , 10% glycerol, 2 mM EDTA, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, 1 g/ml aprotinin, 0.7 g/ml pepstatin). Lysed cells were sonicated briefly, and cellular debris was removed by centrifugation. Lysates were precleared with protein G-agarose beads (Invitrogen) and incubated overnight with protein G-agarose beads and anti-GFP serum (generous gift of William Wickner, Dartmouth Medical School). After immune precipitation with anti-GFP antibody, coprecipitating F-LANA was detected with an antibody that detects full-length F-LANA but not GFP LANA 933-1162. As expected, GFP LANA 933-1162 coprecipitated F-LANA (Fig. 2A, lane 4) but GFP NLS did not (Fig. 2A, lane 2) . GFP fused to LANA 982-1162 1060 FW 1061 (Fig. 2A, lane 6 Table 2 ), demonstrating that none of the replaced residues was essential for LANA oligomerization; instead, amino acids involved in self-association appear to have redundant functions. Further, the finding that the mutants retained the ability to associate with F-LANA is consistent with preservation of the structural integrity of C-terminal LANA in these mutants. Definition of residues critical for C-terminal LANA chromosome binding. To identify residues critical for C-terminal LANA chromosome association, we assayed C-terminal LANA with alanine substitution mutations for the ability to bind mitotic chromosomes. BJAB (uninfected) B-lymphoma cells were transfected with 30 g of C-terminal LANA expression vectors in 400 l of RPMI containing 10% bovine growth serum at 200 V and 960 F with a Bio-Rad electroporator (2) . At 18 to 24 h posttransfection, 0.5 ϫ 10 6 cells/ml were metaphase arrested with 1 g/ml Colcemid (Calbiochem). Colcemid-arrested cells were swollen in hypotonic buffer (1% Na citrate, 10 mM CaCl 2 , 10 mM MgCl 2 ), streaked or cytospun (Thermoshandon) onto slides, and fixed for 10 min in 4% paraformaldehyde (Polysciences). DNA was counterstained with propidium iodide (1 g/ml; Molecular Probes), and coverslips were applied with aqua-poly mount (Polysciences). Microscopy was performed with a Zeiss Axioskop, PCM2000 hardware, and C-imaging software (Compix, Inc.). As expected, GFP NLS (green) was distributed diffusely throughout the cell and did not associate with chromosomes (red, Fig. 1B ).
In contrast, GFP LANA 933-1162 (green) was concentrated in paired dots on a subset of mitotic chromosomes (red, overlay generates yellow, Fig. 1B (Table 2) , were each severely compromised for chromosome binding. These mutants (green) were distributed both diffusely and in dots. The diffuse localization occurred both on and between chromosomes (red; overlay of green and red generates yellow); this distribution differed somewhat from that of GFP NLS, which exclusively localized to the interchromosome space (Fig. 1B) . The dots formed by these mutants were similarly located both on and off chromosomes, and the total number of dots varied from cell to cell. In contrast to the dots formed by GFP LANA 933-1162, those formed by these mutants lacked a defined distribution pattern. Of note, there were isolated examples of paired dots on mitotic chromosomes for the mutants with substitutions at 1060 The seven mutants with severely compromised chromosome association were detected in mitotic cells approximately 10-fold less frequently than GFP LANA 933-1162 or mutants that associated with chromosomes in a wild-type pattern. Further, the chromosome association-deficient mutants were generally detected only when expressed at high levels (Fig. 1B) . The low frequency of detection in mitotic cells, and only when the mutants were expressed at high levels, was similar to the observations with GFP NLS (Fig.  1B) , which does not associate with chromosomes. In contrast, among interphase cells, the frequency of GFP fusion protein detection and expression levels were similar between the wild-type pattern and that of chromosome binding-deficient mutants, indicating that the mutants were expressed at similar levels. This observation was further supported by immunoblot analyses demonstrating that the mutants were expressed at levels similar to that of wild-type C-terminal LANA and GFP NLS ( Fig. 2A and data not Table 2 . (C) Alignment of the C-terminal sequences of LANA and EBNA1 as predicted by 3D-PSSM software (adapted from reference 27). LANA amino acid residues 1023 to 1144 are aligned with EBNA1 residues 474 to 607. Helical (h) and ␤-strand (␤) regions of EBNA1 and the corresponding LANA sequences are indicated (27) . Color coding indicates residues involved in DNA binding as follows: red, important for DNA binding (mutation of red LANA residues results in Յ10% of LANA DNA binding [ Table 2 ]; deletion of red EBNA1 residues results in loss of DNA binding), as demonstrated by EMSA; green, EBNA1 residues that contact DNA and have been shown to be critical for DNA binding by EMSA; blue, EBNA1 residues that contact DNA but have not been assayed (NT) for roles in DNA binding, with the exception of residue 477 K, which has a role in, but is not essential for, DNA binding (7, 9, 12, 15) . Large EBNA1 deletions or mutations that abolished dimerization, which is essential for EBNA1 to bind DNA, were not included. Boxed residues in the LANA sequence indicate residues critical for C-terminal chromosome association. Identification of LANA residues critical for TR DNA binding. We investigated the importance of specific residues for binding to LANA's high-affinity TR binding site. The alanine substitution mutations were each cloned into full-length F-LANA, in vitro translated (TNT reticulocyte lysate system [Promega]), and assayed by electrophoretic mobility shift assay (EMSA) for the ability to bind TR DNA. Similar amounts of F-LANA and F-LANA with alanine substitutions, as determined by Western analysis, were incubated in DNA binding buffer [20 mM Tris (pH 7.5), 10% glycerol, 50 mM KCl, 0.1 mM dithiothreitol, 10 mM MgCl 2 , 1 mM EDTA, 18 g/ml poly(dI-dC)] for 15 min with or without excess unlabeled TR or Ti7 oligonucleotide. TR oligonucleotide consists of a 20-nucleotide LANA binding sequence (3); Ti7 differs from TR by a single C3T base transition that abrogates LANA binding (45) . Fifty thousand counts per minute of 32 P-labeled TR probe was added to each reaction mixture and incubated for 30 min. Bound complexes were resolved in 4% nondenaturing polyacrylamide gels, which were then exposed to Kodak film. Signal intensities of shifted complexes were measured with a Kodak densitometer (Image Station 4000R) and analysis software, and the intensity relative to that of F-LANA was determined ( Table  2) . As expected (3), F-LANA formed two predominant complexes (Fig. 2B , arrows, lanes 2 and 16) that were competed by incubation with 75-fold excess nonradiolabeled TR DNA (Fig.  2B, lane 3) but not DNA containing a mutated TR sequence (Ti7) (Fig. 2B, lane 4) . Unprogrammed reticulocyte lysate did not complex with the TR probe (Fig. 2B, lane 1) .
F-LANA mutants containing C-terminal alanine substitutions were investigated for the ability to bind the TR probe. F-LANA 1068 LKK 1070 (Fig. 2B, lane 8) , F-LANA 1077 FGG 1079 (Fig. 2B, lane 10) , F-LANA 1125 SHP 1127 (Fig. 2B, lane 15) , and F-LANA 1131 NLQ 1133 (Fig. 2B, lane 18) each complexed with the probe at levels similar to that of F-LANA (Fig. 2B, lanes 2  and 16) . F-LANA 1075 FQ 1076 (Fig. 2B, lane 9) and F-LANA 1080 VK 1081 (Fig. 2B, lane 11) formed complexes at modestly reduced levels compared to F-LANA, while F-LANA 1026 DCP 1028 (Fig. 2B, lane 5) , F-LANA 1062 GND 1064 (Fig. 2B,  lane 6 ), F-LANA 1065 PYG 1067 (Fig. 2B, lane 7) , F-LANA 1083 GPV 1085 (Fig. 2B, lane 12) , F-LANA 1119 RL 1120 (Fig. 2B,  lane 13) , F-LANA 1022 WE 1023 (Fig. 2B, lane 14) , and F-LANA 1128 LAG 1130 (Fig. 2B, lane 17) were further reduced with no or barely visible complexes. The relative DNA binding compared to that of F-LANA is summarized for each mutant in Table 2 . Twenty-five of 40 alanine substitution mutants had modest or no reduction in DNA binding and bound at levels at least 40% of that of F-LANA, while 7 mutants bound at levels 12 to 26% of that of F-LANA. The eight mutants with substitutions at 1026 DCP 1028 (Fig. 2B, lane 5 (Table 2) , and 1119 RL 1120 (Fig. 2B, lane 13) were most significantly affected and bound at levels Յ10% of that of F-LANA.
Deficient C-terminal chromosome binding does not reduce LANA-mediated DNA replication. We investigated whether C-terminal chromosome binding has a role in LANA-mediated TR DNA replication. LANA specifically binds to its TR recognition sequence to mediate efficient KSHV DNA replication (24, 27, 29, 33, 39) . In addition, LANA residues involved in N-terminal chromosome attachment are required for replication of TR DNA (4, 37) . A plasmid containing eight copies of the KSHV TR element (p8TR) (3) was purified from Escherichia coli containing Dam methylase, resulting in DNA susceptible to DpnI digestion since DpnI requires Dam methylation for digestion. Following the transfection of p8TR into mammalian cells (which lack Dam methylase), the presence of DpnI-resistant p8TR digestion indicates that DNA replication occurred.
We cotransfected 2 g of p8TR and 2 g of pSG5 (Stratagene), pSG5 expressing F-LANA, LANA 5 (Fig. 3,  lanes 1 to 10) , or 40 g of DNA was digested overnight with 100 U each of DpnI and BglII (Fig. 3, lanes 11 to 20) . Digested DNA was resolved on a 0.8% agarose gel and analyzed by Southern blotting with a 32 P-labeled TR probe. As expected, p8TR DNA replicated in the presence (Fig. 3, lane 13) , but not in the absence (Fig. 3, lane 12) , of F-LANA. F-LANA 1065 PYG 1067 , which is severely compromised for TR DNA binding (4% of LANA binding) (Fig. 2B, lane 7 , and Table 2), was highly impaired for the ability to mediate DNA replication FIG. 3 . DNA replication mediated by LANA alanine substitution mutants. 293 cells were cotransfected with p8TR and pSG5 or pSG5 expressing LANA or LANA containing alanine substitutions. After ϳ80 h, low-molecular-weight DNA was digested with BglII (lanes 1 to 10) or BglII and DpnI (lanes 11 to 20), resolved in a 0.8% agarose gel, blotted onto a nylon membrane, and detected with a TR probe. 293 cell extract, lanes 1 and 11; pSG5, lanes 2 and 12; F-LANA, lanes 3 and 13; F-LANA 5 (Fig. 3, lane 16) , consistent with LANA's requirement to bind TR DNA to mediate replication (33) . In contrast, F-LANA 1062 GND 1064 , which bound TR DNA at a reduced level of 26% of LANA binding (Fig. 2B, lane 6) (Table 2 ), replicated DNA at a level similar to that of F-LANA. It is likely that the lower level of binding, which was assayed by using a single LANA binding site (Fig. 2B, lane 6 , and Table 2 ), is compensated for in the replication assay by F-LANA 1062 GND 1064 cooperatively binding to the two adjacent LANA binding sites located in each TR (24) .
F-LANA 1068 LKK 1070 and F-LANA 1125 SHP 1127 are each severely impaired for C-terminal chromosome binding (Fig.  1B) but bind TR DNA similarly to F-LANA (Fig. 2B , lanes 10 and 15) ( Table 2 ). In contrast, other mutants impaired for C-terminal chromosome association were also deficient for TR DNA binding. Since TR DNA binding is required for DNA replication, only F-LANA 1068 LKK 1070 and F-LANA 1125 SHP 1127 were assayed for DNA replication. Both of these mutants mediated DNA replication (Fig. 3, lanes 17 and 20) at levels similar to those of F-LANA (Fig. 3, lane 13 (Fig. 3, lanes 18 and  19) , the latter two of which contain alanine substitutions that do not affect C-terminal chromosome or DNA binding (Fig. 1B and 2B, lane 10, and Table 2 ). In contrast, and as expected, the N-terminal LANA chromosome binding mutant LANA 5 GMR 7 (Fig. 3, lane 14 ) (4) (Table 2) . Further, residues 1068 LKK 1070 and 1125 SHP 1127 were critical for chromosome attachment but had no effect on TR DNA binding. Thus, DNA binding and chromosome association are mediated by overlapping but distinct C-terminal LANA subdomains.
None of the 40 C-terminal scanning alanine substitution mutants abolished LANA oligomerization. Previously, deletions of ϳ10 to 15 amino acids within LANA amino acids 1025 to 1112 (but not 1007 to 1021) each abolished C-terminal self-association, defining this sequence as critical for oligomerization (33, 43) . Although the alanine substitutions assayed here included residues 1023 to 1145, completely encompassing the self-association region, all retained the ability to oligomerize with LANA ( Fig. 2A, data not shown) . Since no mutation abolished self-association, these data indicate that no specific amino acids are essential for this function. Instead, these results indicate redundancy of function among residues at the oligomerization interface.
This work provides genetic support for the predicted structural similarity between the LANA and EBNA1 DNA binding domains. 3D-PSSM software previously predicted that the structure of the LANA DNA binding domain has homology with the solved structure of the EBNA1 DNA binding domain, despite the absence of primary amino acid homology (27) . Similar to LANA, the EBNA1 DNA binding domain must self-associate to bind its recognition sequence (12) . Further, deletion of LANA residues 1007 to 1021, which correspond to EBNA1 residues that contact DNA, abolished LANA DNA binding (33) . An alignment of the LANA residues mutated in this work and EBNA1 residues is shown in Fig. 2C . LANA amino acid substitutions that decreased DNA binding to Յ10% of that of LANA are shaded red. Residues with roles in EBNA1 binding to DNA are shown in Fig. 2C in red, green, and blue shading. LANA residues important for DNA binding clustering between positions 1026 and 1030, 1065 and 1073, and 1086 and 1088 correspond to clusters of EBNA1 residues critical for binding to cognate DNA (Fig. 2C ). Other residues with roles in LANA DNA binding clustering between positions 1098 and 1106 and positions 1119 and 1120 do not obviously correspond to EBNA1 amino acids critical for DNA recognition. These LANA residues may represent key differences between the DNA binding domains of LANA and EBNA1.
Unlike EBNA1, C-terminal LANA contains a chromosome association function. C-terminal LANA concentrates at pericentromeric and peritelomeric regions of a subset of mitotic chromosomes (32) . C-terminal LANA chromosome association does not occur by binding its recognition sequence in chromosomal DNA and instead is likely mediated through binding to a chromosomal protein. We now identify LANA residues critical for chromosome targeting. Seven alanine substitution mutants were severely compromised for chromosome attachment, indicating that the 18 residues (Fig. 2C , boxed residues) replaced in these mutants are critical for targeting C-terminal LANA to chromosomes. These amino acids lie within, or in close proximity to, predicted helices (Fig. 2C) . These helices may form an interaction surface through which LANA binds to its C-terminal chromosome receptor protein(s).
C-terminal LANA mutants deficient for chromosome association were detected in mitotic cells at about a 10-fold lower frequency than C-terminal LANA or mutants which associated with chromosomes. This infrequent detection was not due to poor expression or unstable protein since C-terminal LANA or mutants that associated with chromosomes and those that were deficient in chromosome association were expressed at similar levels, as detected by immunoblotting, and expression in interphase cells was similar, as detected by microscopy. Further, infrequent detection in mitotic cells also occurred with GFP NLS, which does not associate with chromosomes. A likely possibility is that LANA mutants deficient for mitotic chromosome association are lost from cells during slide preparation. Potentially, during hypotonic swelling of cells, plasma membrane integrity is disrupted, allowing proteins unassociated with chromosomes to leak from the cell. Such leakage could also explain the observed detection of deficient mutants primarily when they are highly expressed.
Although the N-terminal LANA chromosome binding region is essential for mediating TR DNA replication (4, 37, 39) , these data do not support a similar role for C-terminal LANA chromosome attachment. F-LANA with substitutions at with results obtained after triple-alanine substitution of LANA N-terminal residues between positions 5 and 13, which abolished both chromosome association and DNA replication. Further, replacement of N-terminal LANA residues 14 TG 15 results in reduced chromosome association and DNA replication (4, 5) . In contrast, deficient C-terminal chromosome targeting did not reduce LANA-mediated DNA replication.
As one of only a few viral proteins expressed during KSHV latency, LANA has evolved to perform multiple critical functions during latent infection. Among the viral proteins, LANA is necessary and sufficient for both replication and segregation of episomes, ensuring viral persistence (2, 13, 54) . In addition, LANA has effects on transcription, growth control, and apoptosis (1, 19, 20-23, 25, 26, 35, 38, 39, 41-43, 48-51) . Multiple cellular factors bind to LANA, and to the C-terminal domain in particular, and these interactions likely have a critical role in modulating the effect of LANA on both viral persistence and normal cellular processes. Further investigation of LANA should yield insight into the molecular mechanisms underlying its multiple effects.
